Mitchell Chan insider trades

Open-market stock purchases and sales by Mitchell Chan, Chief Financial Officer at REGENXBIO Inc, from SEC Form 4 filings since Mar 2, 2020.

Recent trades

DateStockTradeValue
Sep 1, 2026RGNX REGENXBIO IncSold (not open market)$45.7K
May 6, 2026AVTX Avalo Therapeutics, IncSold$72.5K
Mar 28, 2026AVTX Avalo Therapeutics, IncBought (not open market)—
Jan 6, 2026RGNX REGENXBIO IncBought (not open market)—
Jan 6, 2026RGNX REGENXBIO IncBought (not open market)—

Companies traded

  • RGNX REGENXBIO Inc: other filings, last Sep 1, 2026
  • AVTX Avalo Therapeutics, Inc: 1 sale, last May 6, 2026
  • VIE Viela Bio, Inc: other filings, last Mar 15, 2021

Get free alerts when Mitchell Chan files a new trade →